AXIM Biotechnologies Inc (OTCMKTS:AXIM) Stock Gains After Signing Exclusive Global Commercialization Agreement

September 20, 2022

It was a strong start to the new trading week for shareholders in AXIM Biotechnologies Inc (OTCMKTS:AXIM) as the company’s stock went on a rally and ended the day with gains of as much as 10% amidst significant interest. Trading Data On Monday, AXIM stock surged 9.60% to $0.0965 with more than 441.85K shares, compared to its average volume of 468.09K shares. The stock moved within a range of $0.0820…

Read More >>